{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T08:53:36Z","timestamp":1784192016169,"version":"3.55.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[1995,10,1]],"date-time":"1995-10-01T00:00:00Z","timestamp":812505600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Epidemiol"],"published-print":{"date-parts":[[1995,10]]},"DOI":"10.1007\/bf01719304","type":"journal-article","created":{"date-parts":[[2005,6,12]],"date-time":"2005-06-12T06:25:10Z","timestamp":1118557510000},"page":"527-533","source":"Crossref","is-referenced-by-count":17,"title":["Human T-cell leukemia virus type II infection among high risk groups and its influence on HIV-1 disease progression"],"prefix":"10.1007","volume":"11","author":[{"given":"Magnani","family":"Giacomo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elia Gian","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casoli","family":"Claudio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calzetti","family":"Carlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Degli Antoni","family":"Anna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donatini","family":"Anna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiaccadori","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF01719304_CR1","doi-asserted-by":"crossref","first-page":"8840","DOI":"10.1073\/pnas.87.22.8840","volume":"87","author":"MD Lairmore","year":"1990","unstructured":"Lairmore MD, Jacobson S, Garcia F, et al. Isolation of human T-lymphotropic virus type 2 from Guayami Indians in Panama. Proc Natl Acad Sci USA 1990; 87: 8840\u20138844.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF01719304_CR2","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/infdis\/166.1.100","volume":"166","author":"BM Maloney","year":"1992","unstructured":"Maloney BM, Biggar RJ, Neel JV, et al. Endemic human T-cell lymphotropic virus type II infection among isolated Brazilian Amerindians. J Infect Dis 1992; 166: 100\u2013107.","journal-title":"J Infect Dis"},{"key":"BF01719304_CR3","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1126\/science.2655084","volume":"224","author":"H Lee","year":"1989","unstructured":"Lee H, Swanson P, Shorty VS, et al. High rate of HTLV-II infection in seropositive IV drug abusers in New Orleans. Science 1989; 224: 471\u2013475.","journal-title":"Science"},{"key":"BF01719304_CR4","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1089\/aid.1990.6.561","volume":"6","author":"S Kwok","year":"1990","unstructured":"Kwok S, Gallo D, Hanson C, et al. High prevalence of HTLV-II among intravenous drug abusers: PCR confirmation and typing. AIDS Res Hum Retrovir 1990; 6: 561\u2013565.","journal-title":"AIDS Res Hum Retrovir"},{"key":"BF01719304_CR5","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1056\/NEJM199202063260604","volume":"326","author":"RF Khabbaz","year":"1992","unstructured":"Khabbaz RF, Onorato IM, Cannon RO, et al. Seroprevalence of HTLV-I and HTLV-II among intravenous drug users and persons in clinics for sexually transmitted diseases. N Engl J Med 1992; 326: 375\u2013380.","journal-title":"N Engl J Med"},{"key":"BF01719304_CR6","doi-asserted-by":"crossref","unstructured":"Zella D, Mori L, Sala M, et al. HTLV-II infection in Italian drug abusers. Lancet 1990 (ii): 575\u2013576.","DOI":"10.1016\/0140-6736(90)92140-D"},{"key":"BF01719304_CR7","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1001\/jama.1991.03460050051018","volume":"265","author":"OE Varnier","year":"1991","unstructured":"Varnier OE, Alexander SS, Forbis RM, et al. HTLV seroactivity in Italian intravenous drug addicts is primarily due to HTLV-II infection. J Am Med Ass 1991; 265: 597.","journal-title":"J Am Med Ass"},{"key":"BF01719304_CR8","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/0277-5379(91)90128-Z","volume":"27","author":"A Rossi De","year":"1991","unstructured":"De Rossi A, Mammano F, De Mistro A, et al. Serological and molecular evidence of infection by human T-cell lymphotropic virus type II in Italian drug addicts by use of syntetic peptides and polymerase chain reaction. Eur J Cancer 1991; 27: 835\u2013838.","journal-title":"Eur J Cancer"},{"key":"BF01719304_CR9","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1056\/NEJM199206253262616","volume":"326","author":"AR Zanetti","year":"1992","unstructured":"Zanetti AR, Galli C. Seroprevalence of HTLV-I and HTLV-II. N Engl J Med 1992; 326: 1783\u20131784.","journal-title":"N Engl J Med"},{"key":"BF01719304_CR10","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1007\/BF00145387","volume":"8","author":"AR Zanetti","year":"1992","unstructured":"Zanetti AR, Zehender G, Tanzi E, et al. HTLV-II among Italian intravenous drug users and hemophiliacs. Eur J Epidemiol 1992; 8: 702\u2013707.","journal-title":"Eur J Epidemiol"},{"key":"BF01719304_CR11","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1093\/infdis\/168.5.1273","volume":"168","author":"ML Calabr\u00f3","year":"1993","unstructured":"Calabr\u00f3 ML, Luparello M, Grottola A, et al. Detection of human T-lymphotropic virus type IIb in human immunodeficiency virus type 1-coinfected persons in southeastern Italy. J Infect Dis 1993; 168: 1273\u20131277.","journal-title":"J Infect Dis"},{"key":"BF01719304_CR12","first-page":"1228","volume":"6","author":"A Visconti","year":"1993","unstructured":"Visconti A, Visconti L, Bellocco R, et al. HTLV-II\/HIV-1 coinfection and risk for progression to AIDS among intravenous drug users. J Acquir Immune Defic Syndr 1993; 6: 1228\u20131237.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"BF01719304_CR13","unstructured":"Soriano V, Pillonel J, Wicks R, et al. HTLV-I and HTLV-II in Western Europe. 6th International Conference on Human Retrovirology: HTLV Absecon, USA, May 14\u201319, 1994 (Abstract E 140)."},{"key":"BF01719304_CR14","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1126\/science.6981847","volume":"218","author":"VS Kalyanaram","year":"1982","unstructured":"Kalyanaram VS, Sarngadharan MG, Robert-Guroff M, et al. A new subtype of human T-cell leukemia virus (HTLV-II) associated with a variant of hairy cell leukemia. Science 1982; 218: 571\u2013573.","journal-title":"Science"},{"key":"BF01719304_CR15","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1056\/NEJM198608073150606","volume":"315","author":"JD Rosenblatt","year":"1986","unstructured":"Rosenblatt JD, Golde DW, Wachsman W, et al. A second isolated of HTLV-II associated with a variant of hairy cell leukemia. N Eng J Med 1986; 315: 372\u2013377.","journal-title":"N Eng J Med"},{"key":"BF01719304_CR16","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1182\/blood.V80.5.1116.1116","volume":"80","author":"RP Loughran Jr","year":"1992","unstructured":"Loughran Jr RP, Coyle T, Sherman MP, et al. Detection of human T-cell leukemia\/lymphoma virus, type II, in a patient with large granular lymphocytic leukemia. Blood 1992; 80: 1116\u20131119.","journal-title":"Blood"},{"key":"BF01719304_CR17","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/0140-6736(92)90797-7","volume":"339","author":"B Hjelle","year":"1992","unstructured":"Hjelle B, Appenzeller O, Mills R, et al. Chronic neurodegenerative disease associated with HTLV-II infection. Lancet 1992; 339: 645\u2013646.","journal-title":"Lancet"},{"key":"BF01719304_CR18","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1212\/WNL.41.1.85","volume":"41","author":"JR Berger","year":"1991","unstructured":"Berger JR, Avenningsson A, Raffanti S, et al. Tropical spastic paraparesis-like illness occurring in a patient dually infected with HIV-1 and HTLV-II. Neurology 1991; 41: 85\u201387.","journal-title":"Neurology"},{"key":"BF01719304_CR19","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/0140-6736(93)90529-P","volume":"341","author":"EL Murphy","year":"1993","unstructured":"Murphy EL, Engstrom JW, Miller K, et al. HTLV-II associated myelopathy in a 43 year old woman. Lancet 1993; 341: 757\u2013758.","journal-title":"Lancet"},{"key":"BF01719304_CR20","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/0002-9343(91)90132-H","volume":"91","author":"MH Kaplan","year":"1991","unstructured":"Kaplan MH, Hall WW, Susin M, et al. Syndrome of severe skin disease, eosinophilia and dermatopathic lymphadenopathy in patients with HTLV-II complicating human immunodeficiency virus infections. Am J Med 1991; 91: 300\u2013309.","journal-title":"Am J Med"},{"key":"BF01719304_CR21","unstructured":"Weiss SH, Klein C, French J, et al. Mortality associated with human T-cell lymphotropic virus type 2 (HTLV-2) infection in intravenous drug abusers. Presented at the 7th International Conference on AIDS. Florence, June 1991 (Abstract TH. C. 1001)."},{"key":"BF01719304_CR22","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/0140-6736(90)91456-K","volume":"335","author":"JB Page","year":"1990","unstructured":"Page JB, Lai SH, Chitwood DD, et al. HTLV-I\/II seropositivity and death from AIDS among HIV-1 seropositive intravenous drug users. Lancet 1990; 335: 1439\u20131441.","journal-title":"Lancet"},{"key":"BF01719304_CR23","unstructured":"Hershow RC, Fukuda K, Graber J, et al. Does HTLV-II coinfection predict clinical progression in HIV-infected drug users? Presented at the 10th International Conference on AIDS. Yokoama, August 1994 (Abstract PC 0210)."},{"key":"BF01719304_CR24","first-page":"334","volume":"35","author":"Centers for Disease Control","year":"1986","unstructured":"Centers for Disease Control: Classification system for human T-lymphotropic virus type III\/lymphadenopathy-associated virus infections. MMWR 1986; 35: 334\u2013339.","journal-title":"MMWR"},{"key":"BF01719304_CR25","unstructured":"Morb Mortal Wkly Rep. Licensure of screening tests for antibodies to human T-lymphotropic virus type I. 1988; 37: 736\u2013740, 745\u2013747."},{"key":"BF01719304_CR26","doi-asserted-by":"crossref","first-page":"448","DOI":"10.7326\/0003-4819-118-6-199303150-00009","volume":"118","author":"Centers for Disease Control","year":"1993","unstructured":"Centers for Disease Control. Guidelines for counseling persons infected with Human T-Lymphotropic Virus Type I (HTLV-I) and Type II (HTLV-II). Ann Intern Med 1993; 118: 448\u2013454.","journal-title":"Ann Intern Med"},{"key":"BF01719304_CR27","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3109\/00365549409011774","volume":"26","author":"A Krook","year":"1994","unstructured":"Krook A, Blomberg J. HTLV-II among injecting drug users in Stockholm. Scand J Infect Dis 1994; 26: 129\u2013132.","journal-title":"Scand J Infect Dis"},{"key":"BF01719304_CR28","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1096\/fasebj.5.10.1676689","volume":"5","author":"ZF Rosenberg","year":"1991","unstructured":"Rosenberg ZF, Fauci AS. Immunopathogenesis of HIV infection. FASEB 1991; 5: 2382\u20132390.","journal-title":"FASEB"},{"key":"BF01719304_CR29","doi-asserted-by":"crossref","unstructured":"Bartholomew C, Blatter W, Cleghorn F. Progression to AIDS in homosexual men co-infected with HIV and HTLV_I in Trinidad. Lancet 1987 (ii): 1469.","DOI":"10.1016\/S0140-6736(87)91172-X"},{"key":"BF01719304_CR30","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0140-6736(90)92060-U","volume":"336","author":"HH Lefrere","year":"1990","unstructured":"Lefrere HH, Courouce AM, Mariotti M, et al Rapid progression to AIDS in dual HIV\/HTLV-I infection. Lancet 1990; 336: 509.","journal-title":"Lancet"},{"key":"BF01719304_CR31","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1128\/JVI.63.4.1578-1586.1989","volume":"63","author":"E B\u00f6hnlein","year":"1989","unstructured":"B\u00f6hnlein E, Siekevitz M, Ballard DW, et al. Stimulation of HIV-1 enhancer by HTLV-I tax gene product involves the action of inducible cellular proteins. J Virol 1989; 63: 1578\u20131786.","journal-title":"J Virol"},{"key":"BF01719304_CR32","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1126\/science.2835813","volume":"240","author":"JA Zack","year":"1988","unstructured":"Zack JA, Caan AJ, Lugo JD, et al. HIV-1 production from peripheral blood cells after HTLV-I induced mitogenic stimulation. Science 1988; 240: 1026\u20131029.","journal-title":"Science"},{"key":"BF01719304_CR33","doi-asserted-by":"crossref","first-page":"6341","DOI":"10.1128\/JVI.64.12.6341-6344.1990","volume":"64","author":"P Lusso","year":"1990","unstructured":"Lusso P, Lori F, Gallo RC. CD4-indipendent infection by human immunodeficiency virus type 1 after phenotypic mixing with human T-cell leukemia viruses. J Virol 1990; 64: 6341\u20136344.","journal-title":"J Virol"},{"key":"BF01719304_CR34","doi-asserted-by":"crossref","first-page":"5682","DOI":"10.1128\/JVI.64.11.5682-5687.1990","volume":"64","author":"JH Richardson","year":"1990","unstructured":"Richardson JH, Edwards AJ, Cruickshannk JK, et al. In vivo cellular tropism of human T-cell leukemia virus type 1. J Virol 1990; 64: 5682\u20135687.","journal-title":"J Virol"},{"key":"BF01719304_CR35","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1084\/jem.176.1.293","volume":"176","author":"S Ijichi","year":"1992","unstructured":"Ijichi S, Ramundo MB, Takahashi H, et al. In vivo cellular tropism of human T-cell leukemia virus type II (HTLV-II). J Exp Med 1992; 176: 293\u2013296.","journal-title":"J Exp Med"},{"key":"BF01719304_CR36","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1006\/viro.1995.1036","volume":"206","author":"C Casoli","year":"1995","unstructured":"Casoli C, Cimarelli A, Bertazzoni U. Cellular tropism of human T-cell leukemia virus type II is enlarged to B lymphocites in patients with high proviral load. Virology 1995; 206: 1126\u20131128.","journal-title":"Virology"}],"container-title":["European Journal of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01719304.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01719304\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01719304","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T17:32:23Z","timestamp":1586280743000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01719304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,10]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1995,10]]}},"alternative-id":["BF01719304"],"URL":"https:\/\/doi.org\/10.1007\/bf01719304","relation":{},"ISSN":["0392-2990","1573-7284"],"issn-type":[{"value":"0392-2990","type":"print"},{"value":"1573-7284","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,10]]}}}